Navigation Links
TransEnterix Inc. Names Experienced Medical Device Executive Todd M. Pope as President, CEO
Date:9/24/2008

RESEARCH TRIANGLE PARK, N.C., Sept. 24 /PRNewswire/ -- TransEnterix, an early-stage, privately-held medical device company focused on advanced minimally invasive surgery, announced today that the Board of Directors has named Todd M. Pope the Company's first President and Chief Executive Officer. Mr. Pope has spent nearly 20 years in the medical device market with experience in cardiovascular, peripheral vascular, neurovascular, and laparoscopic surgery.

Mr. Pope, 43, was most recently the Worldwide President of Cordis, a multibillion dollar franchise within Johnson and Johnson's medical device sector.

"TransEnterix has made rapid and substantial progress since securing its first institutional financing this past December," said Fred McCoy, Chairman of the Board. "Now preparing to enter the extensive minimally-invasive surgery market, which is expected to be an $8 billion global market in 2008, it is essential to have seasoned and successful CEO leadership. Todd Pope is just such a leader."

Mr. Pope spent a total of 10 years at various leadership positions at Johnson and Johnson and Boston Scientific before joining TransEnterix.

"It has been my good fortune to have participated in two of the most significant growth revolutions in medical devices with laparoscopic surgery in the 1990s and drug-eluting stents in the early 2000s," Mr. Pope said. "We believe our company is poised to experience tremendous growth for years to come and I am excited to have the opportunity to lead TransEnterix from its earliest stages."

Mr. Pope is a Raleigh native and a graduate of the University of North Carolina at Chapel Hill. He and his family currently reside in Chapel Hill, NC.

About TransEnterix

TransEnterix, Inc. was founded in 2006 and in December, 2007, secured $21 million in its first round of institutional financing. The company is rapidly developing single port and NOTES (Natural Orifice Translumenal Endoscopic Surgery) product platforms for procedures that currently use traditional laparoscopic approaches.

Contact: Len Hall

Allen & Caron Inc

Len@allencaron.com

949.474.4300


'/>"/>
SOURCE TransEnterix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
2. Mediware Names Thomas K. Mann Chief Executive Officer
3. Cleveland-based Health Care Tech Company Within3 Names New CEO
4. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
5. Patient Safety Authority Board of Directors Names Infection Advisory Panel
6. Hooper Holmes Names Chris Behling President of Health & Wellness Division
7. MDMA Names New Director of Federal Affairs
8. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
9. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
10. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
11. Arthur M. Blank Family Foundation Names Susan Bertonaschi Program Officer, Better Beginnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... 2017 , ... At Hallmark Nameplate, their commitment to quality is what sets ... ISO 13485. This certification is another way they are making constant strides to provide ... they need. , The ISO 13485 Certification is a major accomplishment for Hallmark Nameplate ...
(Date:1/18/2017)... ... January 18, 2017 , ... Michael ... new website for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. ... in the field of biosimilars through thought leader interaction in, live video and ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... problems ranging from gum disease to enamel erosion, and those dental problems can ... Department of Public Health, many pregnant women are failing to get the dental ...
(Date:1/17/2017)... ... January 17, 2017 , ... Anesthesia Progress – Everyone ... choose the best drug option for each patient. Dentists have several general anesthesia alternatives ... outcomes. , Researchers from the Tokyo Dental College in Tokyo, Japan wanted to find ...
(Date:1/17/2017)... ... January 17, 2017 , ... For breast cancer clinicians and researchers ... those who desire a more intimate review and analysis of its highlights, a novel ... Bedside—is being offered by Imedex on February 4, 2017 in Chicago. Chaired by Kathy ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 2017   Spotlight Innovation Inc. (OTCQB: ... in the second quarter of 2017, to launch ... to provide relief from chronic pain, is a ... was developed under a licensing agreement with Dr. ... from snake venom. Additionally, Caretta Therapeutics has signed ...
(Date:1/18/2017)... , Jan 18, 2017 Research and Markets ... Vomiting Drugs Market 2017-2021" report to their offering. ... The global CINV drugs ... 2017-2021. Global Thoracic Surgery Market 2017-2021, has been ... experts. The report covers the market landscape and its growth prospects ...
(Date:1/18/2017)... -- In China , we say Health ... of China,s Healthy Strategy originates. 2016 ... Economic and Social Development of the People,s Republic ... state council of the People,s Republic of China ... development plan, identifying medical devices as one of the main ...
Breaking Medicine Technology: